TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11938827

Group type: EXPERIMENTAL
Intervention: 912 compound (Chinese herbal preparation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 9357941

Group type: EXPERIMENTAL
Intervention: Auditory evoked responses in preterm infants
Number of subjects: 81

Group type: COMPARATOR
Intervention: Healthy term infants (control)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Low risk preterm infants
Number of subjects: 81
Study: 8226711

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate 60 mg twice a day (Group 1)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Ferric polymaltose 100 mg daily (Group 2)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Ferric polymaltose 100 mg twice a day (Group 3)
Number of subjects: 159
Study: 3513867

Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP)
Number of subjects: 53
Study: 29142243

Group type: EXPERIMENTAL
Intervention: GRStotal
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: GRSwomen
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: VEGFA rs1358980‐T
Number of subjects: 707
Study: 27366741

Group type: EXPERIMENTAL
Intervention: Plasma Group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Steam Group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 16
Study: 25666686

Group type: EXPERIMENTAL
Intervention: Rusovastatin 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Saliva sampling
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saliva
Number of subjects: 12
Study: 23052531

Group type: EXPERIMENTAL
Intervention: LESS (Laparoendoscopic single-site surgery)
Number of subjects: 57

Group type: COMPARATOR
Intervention: LC (Laparoscopic cholecystectomy)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: LESS
Number of subjects: 57

Group type: COMPARATOR
Intervention: LC
Number of subjects: 57
Study: 21964736

Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site (LESS) cholecystectomy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional laparoscopic (CL) cholecystectomy
Number of subjects: 150
Study: 18359360

Group type: EXPERIMENTAL
Intervention: Memantine (up to 20 mg for 90 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 60
Study: 16988070

Group type: EXPERIMENTAL
Intervention: Very-low-calorie diets (VLCDs) providing <800 kcal/d
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional low-calorie diets (LCDs)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Very-low-calorie diets (VLCDs)
Number of subjects: 6
Study: 14693489

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream
Number of subjects: 1700
Study: 11026791

Group type: EXPERIMENTAL
Intervention: Experimental program in gerontology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control site survey in Pézenas, Hérault
Number of subjects: 0
Study: 10950471

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8472226

Group type: EXPERIMENTAL
Intervention: Experimental group (no urinary diversion and urethral stents)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (with urinary diversion and urethral stents)
Number of subjects: 36
Study: 3530367

Group type: EXPERIMENTAL
Intervention: H/DHE (heparin sodium 5000 units plus dihydroergotamine mesylate 0.5 mg, twice a day)
Number of subjects: 269

Group type: COMPARATOR
Intervention: LMWH/DHE (low molecular weight heparin 1500 units plus dihydroergotamine mesylate 0.5 mg, once a day)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: H/DHE
Number of subjects: 269

Group type: COMPARATOR
Intervention: LMWH/DHE
Number of subjects: 269
Study: 29904753

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid with 2% chlorhexidine (CHX) applied with Scotchbond Universal Adhesive (SBU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 37% phosphoric acid (CTR) applied with Scotchbond Universal Adhesive (SBU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 37% phosphoric acid (CTR) applied with Adper Single Bond 2 (SB2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid with 2% chlorhexidine (CHX) applied with Adper Single Bond 2 (SB2)
Number of subjects: 80
Study: 27531188

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 136
Study: 26697289

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy (CSMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (sham manipulation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (usual non‐manual management)
Number of subjects: 120
Study: 22826019

Group type: EXPERIMENTAL
Intervention: Children's Appetite Awareness Training (CAAT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 47
Study: 20518178

Group type: EXPERIMENTAL
Intervention: Acupuncture (Hegu, Quchi, Neiguan, Zhigou) for 30 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture (Zusanli, Shangjuxu, Xiajuxu, Sanyinjiao) for 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: No acupuncture (Control group)
Number of subjects: 60
Study: 19294863

Group type: EXPERIMENTAL
Intervention: Zhizhuwan (ZZ) 90 g per day for 1 month
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cisapride 30 mg per day for 1 month
Number of subjects: 28
Study: 16905552

Group type: EXPERIMENTAL
Intervention: Tailored pre-operative intervention for excessive alcohol consumption (n = 45)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care (Control group, n = 91)
Number of subjects: 136
Study: 12952112

Group type: EXPERIMENTAL
Intervention: Fexofenadine hydrochloride (180 mg)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 11009855

Group type: EXPERIMENTAL
Intervention: Knowledge of mammography guidelines
Number of subjects: 2239

Group type: EXPERIMENTAL
Intervention: Knowledge of Pap smear guidelines
Number of subjects: 2239

Group type: EXPERIMENTAL
Intervention: Attitudes toward cancer
Number of subjects: 2239

Group type: EXPERIMENTAL
Intervention: Screening participation
Number of subjects: 2239
Study: 8712292

Group type: EXPERIMENTAL
Intervention: Focal anaplasia (FA)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Diffuse anaplasia (DA)
Number of subjects: 165
Study: 1930916

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine (Catapres‐TTS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral clonidine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Transdermal clonidine
Number of subjects: 16
Study: 6890761

Group type: EXPERIMENTAL
Intervention: Zinc acetate supplementation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31733990

Group type: EXPERIMENTAL
Intervention: 25mg/d mirabegron
Number of subjects: 100

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 100
Study: 31623223

Group type: EXPERIMENTAL
Intervention: Four-week Mediterranean diet intervention (MD) for non-adherers from the UK
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (long-term MD adherers from Greece)
Number of subjects: 2
Study: 28441856

Group type: EXPERIMENTAL
Intervention: Ulinastatin combined with somatostatin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Somatostatin (control)
Number of subjects: 42
Study: 25302551

Group type: EXPERIMENTAL
Intervention: Fear of death scale (Study 1)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Writing about own death (Study 2)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Public speaking scale (Study 1)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Writing about dental pain (Study 2)
Number of subjects: 236
Study: 23170828

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 358

Group type: COMPARATOR
Intervention: Control
Number of subjects: 358
Study: 21777884

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 593

Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 593
Study: 19622627

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (1.0 mg/m² . d)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 16700848

Group type: EXPERIMENTAL
Intervention: Sedated group
Number of subjects: 58

Group type: COMPARATOR
Intervention: Nonsedated group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 15605000

Group type: COMPARATOR
Intervention: 15 to 25 mL injection of 1:10,000 solution of epinephrine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 35 to 45 mL injection of 1:10,000 solution of epinephrine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 35 to 45 mL injection of 1:10,000 solution of epinephrine for gastric body ulcers
Number of subjects: 72

Group type: COMPARATOR
Intervention: 15 to 25 mL injection of 1:10,000 solution of epinephrine for gastric body ulcers
Number of subjects: 72
Study: 11574380

Group type: EXPERIMENTAL
Intervention: Modified subgluteus posterior approach
Number of subjects: 128

Group type: COMPARATOR
Intervention: Classic posterior sciatic nerve block (Group Labat)
Number of subjects: 128
Study: 9138173

Group type: COMPARATOR
Intervention: Cremophor EL-solubilized preparation of vitamin K1 (Konakion drops)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mixed-micellar preparation of vitamin K1 (Konakion MM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study: 8834961

Group type: EXPERIMENTAL
Intervention: School of asthma (22 patients attended the school)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (22 patients did not attend the school)
Number of subjects: 360
Study: 2083195

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg plus amiloride 5 mg (HA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg twice daily (F)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Felodipine ER 10 mg daily (FER)
Number of subjects: 18
Study: 378011

Group type: EXPERIMENTAL
Intervention: Intraperitoneal drains
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nasogastric tubes
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intraperitoneal drain
Number of subjects: 100
Study: 30678029

Group type: EXPERIMENTAL
Intervention: Whey proteins
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maltodextrins
Number of subjects: 9
Study: 29197218

Group type: EXPERIMENTAL
Intervention: Authentic acupuncture
Number of subjects: 196

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 196

Group type: COMPARATOR
Intervention: Low-calorie diet alone
Number of subjects: 196
Study: 25629803

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (8-week group intervention including mindfulness, gentle yoga, and music)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 25123755

Group type: EXPERIMENTAL
Intervention: Moderate/severe diabetic retinopathy (DR)
Number of subjects: 3369

Group type: EXPERIMENTAL
Intervention: No/mild diabetic retinopathy (DR)
Number of subjects: 3369
Study: 22190065

Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg b.i.d. for 5 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20081560

Group type: EXPERIMENTAL
Intervention: Surgical treatment for spinal stenosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative treatment for spinal stenosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment for spinal stenosis with degenerative spondylolisthesis
Number of subjects: 0
Study: 17430285

Group type: EXPERIMENTAL
Intervention: arts‐based observational skills training for 90 minutes
Number of subjects: 68

Group type: COMPARATOR
Intervention: practical training in the management of psoriasis
Number of subjects: 68
Study: 15897164

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate baths
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11994341

Group type: EXPERIMENTAL
Intervention: 0.5 g strontium ranelate per day
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: 1 g strontium ranelate per day
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: 2 g strontium ranelate per day
Number of subjects: 353

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 353
Study: 10366258

Group type: EXPERIMENTAL
Intervention: Reinforcing Kidney and Invigorating Spleen Principle (RKISP) with steroid aerosol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroid aerosol
Number of subjects: 0
Study: 15278814

Group type: EXPERIMENTAL
Intervention: Lidocaine patch applied for 15 min (Group A)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lidocaine patch applied for 30 min (Group B)
Number of subjects: 26
Study: 2958035

Group type: EXPERIMENTAL
Intervention: P-contrast (1 g/cm3)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Barium (Mixobar Ventrikel 400 mg/ml)
Number of subjects: 122
Study: 31022311

Group type: EXPERIMENTAL
Intervention: Topical application of mitomycin-C (MMC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Topical application of saline (placebo)
Number of subjects: 15
Study: 30544491

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (maintained unaltered lifestyle)
Number of subjects: 60
Study: 27903344

Group type: EXPERIMENTAL
Intervention: Calcium ionophore A23187 (AOA group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine ICSI operation (Control group)
Number of subjects: 180
Study: 25424464

Group type: EXPERIMENTAL
Intervention: Integrated and replicable physical activity programme with approximately 60 minutes of physical activity during school in the second year, along with nutritional education.
Number of subjects: 321

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Integrated and replicable physical activity programme with nutritional education.
Number of subjects: 321
Study: 23029716

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg orally, three times a day for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 20460237

Group type: EXPERIMENTAL
Intervention: Group A (6+/‐2 mg/kg)
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Group B (15+/‐2 mg/kg)
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Group C (24+/‐2 mg/kg)
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Group D (34+/‐2 mg/kg)
Number of subjects: 1099
Study: 18687842

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:80,000 Adrenalin
Number of subjects: 20
Study: 15958399

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (two tablets daily)
Number of subjects: 70
Study: 12101458

Group type: EXPERIMENTAL
Intervention: Improved biofeedback integrated system (Ibis) applied to vision
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 28
Study: 10419812

Group type: EXPERIMENTAL
Intervention: Localization of the AT(1) receptor using immunocytochemistry; expression of prorenin, angiotensinogen, and AT(1) receptor mRNA using RT-PCR.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Localization and expression of RAS components in the placenta; no control group mentioned.
Number of subjects: 0
Study: 7556823

Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Intermittent injections (CIT)
Number of subjects: 255
Study: 1763599

Group type: EXPERIMENTAL
Intervention: 0.1 mg fentanyl
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 0.5 mg alfentanil
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Postoperative pain
Number of subjects: 164
Study: 7073148

Group type: EXPERIMENTAL
Intervention: Low-dose heparin prophylaxis (5000 U twice daily)
Number of subjects: 1358

Group type: COMPARATOR
Intervention: Control group (no heparin treatment)
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Low-dose heparin prophylaxis
Number of subjects: 1358
Study: 31781682

Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (0.5 mg on alternate days for 24 weeks) combined with conventional glucocorticoids and immunosuppressants
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional glucocorticoids and immunosuppressants
Number of subjects: 62
Study: 28731372

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (14,000 IU/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 27340985

Group type: EXPERIMENTAL
Intervention: Smartphone hearing application (Hearing Test™ software)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pure‐tone audiogram
Number of subjects: 0
Study: 24725785

Group type: EXPERIMENTAL
Intervention: Pilates exercise (30-min home-based exercises, 5 times per week for 8 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no Pilates exercise)
Number of subjects: 80
Study: 21993073

Group type: EXPERIMENTAL
Intervention: Therapeutic exchange program (educational sessions for physicians)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no therapeutic exchange program)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intervention region
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control region
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 19351628

Group type: EXPERIMENTAL
Intervention: Steerable sheath (Agilis NXT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fixed-curve sheath (Mullins sheath)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 56
Study: 17113170

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg once daily for 3-6 weeks, followed by 16 mg once daily for 6 months
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 15066944

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine, 12.5 to 25 mg PO with 16 oz of water
Number of subjects: 13

Group type: COMPARATOR
Intervention: Phenylpropanolamine, 12.5 to 25 mg PO
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine, 30 mg PO with 16 oz of water
Number of subjects: 13
Study: 11238281

Group type: EXPERIMENTAL
Intervention: Intracoronary irradiation (gamma rays)
Number of subjects: 0
Study: 10921031

Group type: EXPERIMENTAL
Intervention: ATRA (10(-6) mmol/L)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intermittent therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ATRA treatment
Number of subjects: 18
Study: 8080349

Group type: EXPERIMENTAL
Intervention: Buspirone therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 2685709

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healon) injection (0.50 to 0.75 ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no sodium hyaluronate injection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 1272686

Group type: EXPERIMENTAL
Intervention: Sedative medications
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control conditions (no specific control mentioned)
Number of subjects: 36
Study: 30992031

Group type: EXPERIMENTAL
Intervention: Precise visual feedback condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Obscure visual feedback condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: No visual feedback condition
Number of subjects: 20
Study: 27614416

Group type: EXPERIMENTAL
Intervention: Advanced bipolar device
Number of subjects: 41

Group type: COMPARATOR
Intervention: Traditional tie and suture
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study: 25732157

Group type: EXPERIMENTAL
Intervention: Continuous androgen deprivation (CAD)
Number of subjects: 0
Study: 23702601

Group type: EXPERIMENTAL
Intervention: Real-time cardiopulmonary resuscitation guidance
Number of subjects: 141
Study: 21851368

Group type: EXPERIMENTAL
Intervention: Laser group treated with Er:YAG laser irradiation (30 mJ per pulse, 10 pps, 60 s)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L‐MTAD group treated with laser irradiation plus a mixture of doxycycline, tetracycline isomer and citric acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: RC‐Prep group treated with EDTA gel or cream (RC‐Prep)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group left untreated
Number of subjects: 0
Study: 17619911

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim beginning with cycle 1 (primary prophylaxis)
Number of subjects: 852

Group type: COMPARATOR
Intervention: Pegfilgrastim subsequent to cycle 1 at clinicians' discretion (usual care)
Number of subjects: 852
Study: 16254422

Group type: EXPERIMENTAL
Intervention: Heparin plus nitroglycerin and verapamil (Group A)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Heparin plus nitroglycerin (Group B)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Heparin alone (Group C)
Number of subjects: 406
Study: 14586186

Group type: EXPERIMENTAL
Intervention: Enhanced cognitive-behavioral intervention (9 sessions, 4 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard counseling and testing intervention (2 sessions)
Number of subjects: 100
Study: 10639039

Group type: EXPERIMENTAL
Intervention: SonoVue 0.03 mL/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue 0.3 mL/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue (both dosages)
Number of subjects: 12
Study: 9022223

Group type: EXPERIMENTAL
Intervention: Adult eye contact maintained during Periods 1 and 3, averted during Periods 2 and 4
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control infants received eye contact during all periods
Number of subjects: 2